Acquisition of Antibiotic-Resistant Gram-negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial
- PMID: 31970393
- PMCID: PMC7850534
- DOI: 10.1093/cid/ciaa071
Acquisition of Antibiotic-Resistant Gram-negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial
Abstract
Background: The Benefits of Universal Glove and Gown (BUGG) cluster randomized trial found varying effects on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and no increase in adverse events. The aim of this study was to assess whether the intervention decreases the acquisition of antibiotic-resistant gram-negative bacteria.
Methods: This was a secondary analysis of a randomized trial in 20 hospital intensive care units. The intervention consisted of healthcare workers wearing gloves and gowns when entering any patient room compared to standard care. The primary composite outcome was acquisition of any antibiotic-resistant gram-negative bacteria based on surveillance cultures.
Results: A total of 40 492 admission and discharge perianal swabs from 20 246 individual patient admissions were included in the primary outcome. For the primary outcome of acquisition of any antibiotic-resistant gram-negative bacteria, the intervention had a rate ratio (RR) of 0.90 (95% confidence interval [CI], .71-1.12; P = .34). Effects on the secondary outcomes of individual bacteria acquisition were as follows: carbapenem-resistant Enterobacteriaceae (RR, 0.86 [95% CI, .60-1.24; P = .43), carbapenem-resistant Acinetobacter (RR, 0.81 [95% CI, .52-1.27; P = .36), carbapenem-resistant Pseudomonas (RR, 0.88 [95% CI, .55-1.42]; P = .62), and extended-spectrum β-lactamase-producing bacteria (RR, 0.94 [95% CI, .71-1.24]; P = .67).
Conclusions: Universal glove and gown use in the intensive care unit was associated with a non-statistically significant decrease in acquisition of antibiotic-resistant gram-negative bacteria. Individual hospitals should consider the intervention based on the importance of these organisms at their hospital, effect sizes, CIs, and cost of instituting the intervention.
Clinical trials registration: NCT01318213.
Keywords: antibiotic resistance; barrier precautions; contact precautions.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
Similar articles
-
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.JAMA. 2013 Oct 16;310(15):1571-80. doi: 10.1001/jama.2013.277815. JAMA. 2013. PMID: 24097234 Free PMC article. Clinical Trial.
-
Deconstructing the relative benefits of a universal glove and gown intervention on MRSA acquisition.J Hosp Infect. 2017 May;96(1):49-53. doi: 10.1016/j.jhin.2017.03.011. Epub 2017 Mar 16. J Hosp Infect. 2017. PMID: 28410760 Free PMC article. Clinical Trial.
-
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.Ann Intern Med. 1996 Sep 15;125(6):448-56. doi: 10.7326/0003-4819-125-6-199609150-00004. Ann Intern Med. 1996. PMID: 8779456 Clinical Trial.
-
Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.Clin Infect Dis. 2017 May 15;64(suppl_2):S51-S60. doi: 10.1093/cid/cix112. Clin Infect Dis. 2017. PMID: 28475791 Review.
-
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.Lancet Infect Dis. 2013 Apr;13(4):328-41. doi: 10.1016/S1473-3099(12)70322-5. Epub 2013 Jan 25. Lancet Infect Dis. 2013. PMID: 23352693 Review.
Cited by
-
Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.Infect Control Hosp Epidemiol. 2024 Jun;45(6):703-708. doi: 10.1017/ice.2024.11. Epub 2024 Feb 14. Infect Control Hosp Epidemiol. 2024. PMID: 38351872 Free PMC article.
-
Contact precautions for the control of endemic pathogens: Finding the middle path.Antimicrob Steward Healthc Epidemiol. 2023 Mar 24;3(1):e57. doi: 10.1017/ash.2023.145. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37008747 Free PMC article. No abstract available.
-
Modelling interventions and contact networks to reduce the spread of carbapenem-resistant organisms between individuals in the ICU.J Hosp Infect. 2023 Jun;136:1-7. doi: 10.1016/j.jhin.2023.02.016. Epub 2023 Mar 11. J Hosp Infect. 2023. PMID: 36907332 Free PMC article.
-
Active surveillance testing to reduce transmission of carbapenem-resistant, gram-negative bacteria in intensive care units: a pragmatic, randomized cross-over trial.Antimicrob Resist Infect Control. 2023 Mar 3;12(1):16. doi: 10.1186/s13756-023-01222-2. Antimicrob Resist Infect Control. 2023. PMID: 36869371 Free PMC article. Clinical Trial.
-
Molecular surveillance reveals widespread colonisation by carbapenemase and extended spectrum beta-lactamase producing organisms in neonatal units in Kenya and Nigeria.Antimicrob Resist Infect Control. 2023 Feb 22;12(1):14. doi: 10.1186/s13756-023-01216-0. Antimicrob Resist Infect Control. 2023. PMID: 36814315 Free PMC article.
References
-
- Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173:2039–46. - PubMed
-
- Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG; Antimicrobial Availability Task Force of the Infectious Diseases Society of America Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42:657–68. - PubMed
-
- Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol 2016; 37:1288–301. - PMC - PubMed
-
- World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed Available at: https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-ba.... Accessed 19 March 2019.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
